These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 5016575

  • 1. Metabolism of L-dopa after inhibition of catechol-O-methyl transferase.
    Baldessarini RJ, Chace KV.
    Eur J Pharmacol; 1972 Jan; 17(1):163-6. PubMed ID: 5016575
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ.
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of catechol-O-methyl transferase by catechols and polyphenols.
    Baldessarini RJ, Greiner E.
    Biochem Pharmacol; 1973 Jan 15; 22(2):247-56. PubMed ID: 4763253
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tetrahydroisoquinolines derived from noradrenaline-aldehyde condensations. Pyrogallol-sensitive O-methylation in rat homogenates.
    Rubenstein JA, Collins MA.
    Biochem Pharmacol; 1973 Nov 15; 22(22):2928-31. PubMed ID: 4761559
    [No Abstract] [Full Text] [Related]

  • 8. O-Methylation of 3H-norepinephrine by epididymal adipose tissue.
    Traiger GJ, Calvert DN.
    Biochem Pharmacol; 1969 Jan 15; 18(1):109-17. PubMed ID: 5780981
    [No Abstract] [Full Text] [Related]

  • 9. Glycol sulphate ester formation from ( 14 C)noradrenaline in brain and the influence of a COMT inhibitor.
    Sugden RF, Eccleston D.
    J Neurochem; 1971 Dec 15; 18(12):2461-8. PubMed ID: 5135906
    [No Abstract] [Full Text] [Related]

  • 10. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L, Bruno SJ.
    Biochem Pharmacol; 1973 Feb 01; 22(3):417-25. PubMed ID: 4687136
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potentiation of the L-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors.
    Ericsson AD.
    J Neurol Sci; 1971 Oct 01; 14(2):193-7. PubMed ID: 5112212
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Action of catechol-O-methyltransferase on norepinephrine effects in rats adaptated to various temperatures].
    Laury MC, Bertin R, Portet R, Chevillard L.
    J Physiol (Paris); 1971 May 01; 63(3):318-21. PubMed ID: 5121935
    [No Abstract] [Full Text] [Related]

  • 15. Uptake and metabolism of L-3,4-dihydroxyphenylalanine (DOPA) in rat tissues.
    Landsberg L, Taubin HL.
    Biochem Pharmacol; 1973 Nov 15; 22(22):2789-800. PubMed ID: 4761551
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of serotonin synthesis by dopa and other catechols.
    Goldstein M, Frenkel R.
    Nat New Biol; 1971 Oct 06; 233(40):179-80. PubMed ID: 5287086
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A, Loureiro AI, Vieira-Coelho MA, Hainzl D, Soares-da-Silva P.
    Eur J Pharmacol; 2001 May 18; 420(1):27-32. PubMed ID: 11412836
    [Abstract] [Full Text] [Related]

  • 20. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA, Chalmers JP, Cottman K, Lytle LD, Wurtman RJ.
    J Pharmacol Exp Ther; 1972 Feb 18; 180(2):277-85. PubMed ID: 5010674
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.